We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$133B
1-Year Est. Return
43.5%
This Fund
S&P 500
This Quarter
Est. Return
+26.39%
1 Year Est. Return
+43.5%
3 Year Est. Return
+132.19%
5 Year Est. Return
+175.35%
10 Year Est. Return
+672.4%
AUM
$133B
AUM Growth
+$15.7B
(+13%)
Cap. Flow
-$1.75B
Cap. Flow
% of AUM
-1.32%
Top 10 Holdings %
Top 10 Hldgs %
30.35%
Holding
4,370
New
224
Increased
1,883
Reduced
1,827
Closed
182
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Marvell Technology
MRVL
|
+$117M |
| 2 |
HONA
Honeywell Aerospace
HONA
|
+$117M |
| 3 |
SPCX
SpaceX
SPCX
|
+$100M |
| 4 |
P
Everpure Inc
P
|
+$67.3M |
| 5 |
Roku
ROKU
|
+$53M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$212M |
| 2 |
Microsoft
MSFT
|
+$156M |
| 3 |
Amazon
AMZN
|
+$142M |
| 4 |
Honeywell
HON
|
+$119M |
| 5 |
NVIDIA
NVDA
|
+$94.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.1% |
| 2 | Financials | 11.93% |
| 3 | Industrials | 10.35% |
| 4 | Consumer Discretionary | 9.64% |
| 5 | Healthcare | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2951
Peoples Bancorp of North Carolina
PEBK
$230M
| $231K | ﹤0.01% |
5,362
+19
| +0.4% | +$789 |
|
2952
iShares MSCI Canada ETF
EWC
$6.85B
| $231K | ﹤0.01% |
+4,000
| New | +$231K |
|
2953
Arm
ARM
$331B
| $230K | ﹤0.01% |
650
+87
| +15% | +$23.1K |
|
2954
Karyopharm Therapeutics
KPTI
$36.7M
| $229K | ﹤0.01% |
+23,467
| New | +$204K |
|
|
ONC
2955
BeOne Medicines Ltd
ONC
$40.8B
| $229K | ﹤0.01% |
804
-105
| -12% | -$30.9K |
|
2956
Eagle Bancorp Montana
EBMT
$171M
| $228K | ﹤0.01% |
9,514
+343
| +4% | +$7.7K |
|
2957
Vuzix
VUZI
$248M
| $226K | ﹤0.01% |
77,899
+3,114
| +4% | +$9.81K |
|
|
RMAX
2958
DELISTED
RE/MAX Holdings
RMAX
| $226K | ﹤0.01% |
22,898
+374
| +2% | +$3.26K |
|
|
AII
2959
American Integrity Insurance
AII
$494M
| $225K | ﹤0.01% |
11,946
+4,774
| +67% | +$86.4K |
|
2960
BRC Group Holdings
RILY
$230M
| $224K | ﹤0.01% |
27,895
+26,850
| +2,569% | +$228K |
|
2961
Galectin Therapeutics
GALT
$393M
| $224K | ﹤0.01% |
+48,332
| New | +$125K |
|
2962
Stereotaxis
STXS
$130M
| $224K | ﹤0.01% |
130,042
-2,311
| -2% | -$4.34K |
|
|
ASIC
2963
Ategrity Specialty Insurance
ASIC
$1.3B
| $224K | ﹤0.01% |
9,300
+3,757
| +68% | +$77K |
|
2964
ALX Oncology
ALXO
$181M
| $223K | ﹤0.01% |
+107,902
| New | +$193K |
|
|
SI
2965
Shoulder Innovations Inc
SI
$354M
| $223K | ﹤0.01% |
11,013
+6,269
| +132% | +$96.3K |
|
|
RNA
2966
Atrium Therapeutics
RNA
$142M
| $223K | ﹤0.01% |
16,579
+1,626
| +11% | +$21.2K |
|
2967
Tonix Pharmaceuticals
TNXP
$169M
| $222K | ﹤0.01% |
17,434
+3,266
| +23% | +$42.1K |
|
2968
DiaMedica Therapeutics
DMAC
$428M
| $221K | ﹤0.01% |
31,460
+8,707
| +38% | +$53.5K |
|
2969
Crawford & Co Class A
CRD.A
$595M
| $221K | ﹤0.01% |
19,642
+562
| +3% | +$5.97K |
|
2970
Enel Chile
ENIC
$5.93B
| $221K | ﹤0.01% |
49,107
+340
| +0.7% | +$1.49K |
|
2971
Alector
ALEC
$218M
| $220K | ﹤0.01% |
109,532
+8,205
| +8% | +$17.6K |
|
|
SEG
2972
Seaport Entertainment Group
SEG
$300M
| $219K | ﹤0.01% |
8,246
+2,476
| +43% | +$58.2K |
|
2973
Larimar Therapeutics
LRMR
$320M
| $219K | ﹤0.01% |
71,888
+9,203
| +15% | +$36.5K |
|
2974
Precision BioSciences
DTIL
$172M
| $219K | ﹤0.01% |
27,864
+27,589
| +10,032% | +$194K |
|
2975
Coca-Cola Femsa
KOF
$23.2B
| $219K | ﹤0.01% |
2,060
| – | – |
|
Similar funds
RhumbLine Advisers's Q2 2026 Portfolio in Review
As of Q2 2026, RhumbLine Advisers held 4,370 positions worth $133B, up 13% from $117B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
RhumbLine Advisers's Q2 2026 filing shows 224 new, 1,883 increased, 1,827 reduced and 182 closed positions. Its largest new stake was Honeywell Aerospace: 529,091 shares worth $117M. The largest sale was Apple, an estimated $212M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 31% a quarter earlier, followed by Financials and Industrials.
- RhumbLine Advisers's largest Q2 2026 buy was Honeywell Aerospace: 529,091 shares worth $117M.
- RhumbLine Advisers added most to Marvell Technology in Q2 2026, an estimated $117M increase.
- RhumbLine Advisers's biggest Q2 2026 reduction was Apple, cutting an estimated $212M.
- RhumbLine Advisers fully exited Coterra Energy in Q2 2026, selling an estimated $53.5M.
- RhumbLine Advisers's ten largest holdings make up 30% of its $133B portfolio in Q2 2026.
- RhumbLine Advisers opened 224 new positions and closed 182 in Q2 2026.
- RhumbLine Advisers's portfolio value rose 13% quarter-over-quarter to $133B.
Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.